Ronsheim Matthew
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Ronsheim Matthew. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| INVA | See Remarks | Tax Withholding | 268 | $16.13 | $4,323 | May 20, 2024 |
| INVA | See Remarks | Award / Grant | 12,768 | $14.88 | $189,988 | Mar 5, 2024 |
| INVA | See Remarks | Tax Withholding | 807 | $15.80 | $12,751 | Feb 20, 2024 |
| INVA | See Remarks | Tax Withholding | 1,600 | $16.05 | $25,680 | Jan 18, 2024 |
| 0001724344 | Chief of Pharma Sciences & MFG | Disposition | 150,000 | — | — | Jul 7, 2022 |
| 0001724344 | See Remarks | Award / Grant | 125,000 | — | — | Jan 18, 2022 |
| 0001724344 | Chief, Pharma Sciences & MFG. | Tax Withholding | 3,669 | $2.94 | $10,787 | Nov 2, 2021 |
| 0001724344 | See Remarks | Award / Grant | 25,000 | — | — | Oct 19, 2021 |
| 0001724344 | See Remarks | Award / Grant | 25,000 | — | — | Jan 15, 2021 |